Article

Session 3: Discussant

Jan Berger, MD, MJ, The American Journal of Pharmacy Benefits editor-in-chief, follows Rebecca Killon's remarks with her own insight on the importance of diabetes medication adherence.

Jan Berger, MD, MJ, The American Journal of Pharmacy Benefits editor-in-chief, follows Rebecca Killon’s remarks with her own insight on the importance of diabetes medication adherence.

“I've waited 13 years for adherence to be an important issue. In 2003, when I first got somebody's attention, they looked at me like I was crazy,” said Dr Berger. “It was just a matter of [what] doctors would say to us when we would share with them that their patient was nonadherent. ‘It's not my problem,’ ‘ It's not my fault,’ ‘ It's the patient, we told them what to do.‘“

Dr Berger argues that the only way to truly have a breakthrough, is in the power of physician-patient relationships and alignment. Through better communication, continual learning, and realistic expectations, we can improve adherence rates.

Related Videos
Yael Mauer, MD, MPH
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Beau Raymond, MD
Dr Kevin Mallow, PharmD, BCPS, BC-ADM, CDCES
Ian Neeland, MD
Chase D. Hendrickson, MD, MPH
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Related Content
CH LogoCenter for Biosimilars Logo